(March 20, 2012, Weil News)
Weil, Gotshal & Manges LLP was counsel to global pharmaceutical and healthcare firm Sanofi on its acquisition of Pluromed Inc., a medical device company based in Woburn, Massachusetts. Financial terms of the transaction, which was announced March 16, 2012, were not disclosed. The transaction is subject to customary closing conditions.
Pluromed develops and manufactures injectable plugs to control bleeding during surgical procedures. Under the acquisition agreement, Sanofi will commercialize LeGoo gel, which is used to treat temporary endovascular occlusion of blood vessels during surgery.
Sanofi is a leader in healthcare with core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, and animal health. Paris-based
Sanofi acquired Genzyme Corporation, a leading biotechnology firm, in February 2011.
Weil's team was led by Corporate partner Steven M. Peck and included Corporate partner Joseph Basile and associates David Kapson, Patrick Joy, Ramona Nee, and Alex Purtill; Technology & IP Transactions partner Michael Epstein and associates Cassie Waduge and Janell Wise; Tax partner William Horton and associate Randall Gartin; Employee Benefits partner Andrew Gaines and associates Eric Schecter and Kate Napalkov; and Regulatory partner Doug Nave, counsel John O'Loughlin, associate Thomas Goslin, and paralegal Joseph Rafferty.